Inova Fairfax Hospital issued the following announcement on Nov. 13
We congratulate Palak Shah, MD, MS, Director of the Inova Cardiovascular Genomics Center and Medical Director for Mechanical Circulatory Support for Inova’s Heart Failure, MCS and Transplant program, on receiving the 2021 James T. Willerson Award in Clinical Research. This national award recognizes the best clinical science paper published in Circulation, a major academic journal of the American Heart Association, in 2021!
The article published findings of a new blood test offering a less invasive approach for earlier detection of acute rejection in heart transplant patients. The study describes a DNA-based blood test to detect rejection weeks to months before current clinical tools. This enables physicians to prevent or slow down this potentially deadly condition that occurs most commonly in the first year after a patient has received a donor heart.
The study was primarily funded by the @National Heart, Lung, and Blood Institute (NHLBI), of the National Institutes of Health (NIH). The research team also included Sean Agbor-Enoh, MD, PhD, study co-author and Chief of the Laboratory of Applied Precision Omics at NHLBI, and Hannah Valantine, MD, senior study author and former Lead Investigator of the Laboratory of Organ Transplant Genomics in the Cardiovascular Branch at the NHLBI.
Find additional information about the study at https://bit.ly/Circulation-Shah.
Original source can be found here.
Alerts Sign-up